Manfredi Rizzo

发表的论文15 篇，按出版时间

1. 1
   Tirzepatide data: safety first is safety always!Expert Opinion on Drug Safety20260
2. 2
   rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 InhibitorsTherapeutics and Clinical Risk Management20260
3. 3
   Cardiorenometabolic medicine as a new subspecialty in the light of novel pharmaceuticals with dual or triple benefitsExpert Opinion on Drug Safety20260
4. 4
   Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut MicrobiotaTherapeutics and Clinical Risk Management20256
5. 5
   The Safety, Efficacy, and Clinical Use of Novel Once-Weekly Insulins in the Management of DiabetesExpert Opinion on Drug Safety20250
6. 6
   The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysisExpert Opinion on Drug Safety20258
7. 7
   Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbiditiesExpert Opinion on Drug Safety20240
8. 8
   Tirzepatide and glucagon-like peptide-1 receptor agonists: safety always comes first!Expert Opinion on Drug Safety202312
9. 9
   Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attentionExpert Opinion on Drug Safety20223
10. 10
    Efficacy and safety of finerenone for treatment of diabetic kidney disease: current knowledge and future perspectiveExpert Opinion on Drug Safety202217